JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.17% |
| 2 | Healthcare | 10.79% |
| 3 | Financials | 9.36% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Western Alliance Bancorporation
WAL
$8.98B
| $3.58M | ﹤0.01% |
100,688
-2,056,953
| -95% | -$126M |
|
2952
NovaGold Resources
NG
$3.48B
| $3.58M | ﹤0.01% |
575,261
-26,759
| -4% | -$163K |
|
2953
Scilex Holding
SCLX
$47.5M
| $3.57M | ﹤0.01% |
+12,454
| New | +$3.45M |
|
2954
GitLab
GTLB
$7.2B
| $3.57M | ﹤0.01% |
104,184
-8,479
| -8% | -$372K |
|
2955
CarGurus
CARG
$3.33B
| $3.56M | ﹤0.01% |
190,607
-38,047
| -17% | -$647K |
|
2956
Radiant Logistics
RLGT
$408M
| $3.56M | ﹤0.01% |
542,438
-8,791
| -2% | -$49.1K |
|
|
LITT
2957
DELISTED
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
| $3.55M | ﹤0.01% |
+350,000
| New | +$3.53M |
|
2958
Westamerica Bancorp
WABC
$1.38B
| $3.55M | ﹤0.01% |
80,122
+41,616
| +108% | +$2.24M |
|
2959
Seres Therapeutics
MCRB
$45.6M
| $3.54M | ﹤0.01% |
31,201
+574
| +2% | +$62.1K |
|
2960
Red Rock Resorts
RRR
$3.76B
| $3.54M | ﹤0.01% |
79,384
-136,631
| -63% | -$6.04M |
|
2961
Ligand Pharmaceuticals
LGND
$5.87B
| $3.54M | ﹤0.01% |
48,089
+9,256
| +24% | +$658K |
|
2962
First Bancorp
FBNC
$2.74B
| $3.54M | ﹤0.01% |
99,538
-69,334
| -41% | -$2.76M |
|
|
AMWD
2963
DELISTED
American Woodmark
AMWD
| $3.53M | ﹤0.01% |
67,797
+35,129
| +108% | +$1.9M |
|
|
HSKA
2964
DELISTED
Heska Corp
HSKA
| $3.53M | ﹤0.01% |
36,159
+1,919
| +6% | +$161K |
|
2965
ProShares S&P 500 ex-Financials ETF
SPXN
$80.7M
| $3.52M | ﹤0.01% |
+80,000
| New | +$3.38M |
|
|
AYX
2966
DELISTED
Alteryx Inc
AYX
| $3.51M | ﹤0.01% |
59,628
-1,043,557
| -95% | -$60.8M |
|
2967
Ero Copper
ERO
$3.53B
| $3.51M | ﹤0.01% |
198,841
-68,531
| -26% | -$1.1M |
|
2968
IAMGOLD
IAG
$10.4B
| $3.5M | ﹤0.01% |
1,291,542
+313,127
| +32% | +$797K |
|
|
IBTX
2969
DELISTED
Independent Bank Group, Inc.
IBTX
| $3.5M | ﹤0.01% |
75,501
+32,208
| +74% | +$1.83M |
|
|
ROVR
2970
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $3.5M | ﹤0.01% |
772,187
+159,002
| +26% | +$641K |
|
2971
SmartFinancial
SMBK
$902M
| $3.49M | ﹤0.01% |
151,018
-44,540
| -23% | -$1.16M |
|
2972
Hims & Hers Health
HIMS
$6.57B
| $3.49M | ﹤0.01% |
351,715
+226,226
| +180% | +$1.98M |
|
2973
BancFirst
BANF
$3.89B
| $3.49M | ﹤0.01% |
41,992
+19,957
| +91% | +$1.72M |
|
2974
ProShares S&P 500 ex-Energy ETF
SPXE
$87.7M
| $3.49M | ﹤0.01% |
+80,000
| New | +$3.39M |
|
2975
Aclaris Therapeutics
ACRS
$851M
| $3.47M | ﹤0.01% |
429,167
+1,507
| +0.4% | +$19.1K |
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 752 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 752 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.